Regulatory, Patent Reform Needed for Inhalers for Asthma, COPD
Manufacturers have employed various strategies to obtain regulatory exclusivities and patents on inhalers, limiting generic competition (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 21, 2022 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Internal Medicine, Allergy, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Tezepelumab Effective for Severe, Uncontrolled Asthma
Nearly half of patients experience a complete response to treatment across multiple measures (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 20, 2022 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Emergency Medicine, Pediatrics, Pharmacy, Pulmonology, Conference News, Source Type: news

Psychological Distress May Increase Risk for COVID-19 Hospitalization
FRIDAY, May 20, 2022 -- For patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, psychological distress prior to the diagnosis is associated with hospitalization for COVID-19, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2022 Category: Pharmaceuticals Source Type: news

COVID-19 rapid guideline: managing COVID-19 [NG191], NICE (updated 19th May 2022)
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily. We are continually monitoring the evidence and updating the guideline as new information emerges. On 19 May 2022, we replaced 2 recommendations about advice to give to people with COVID-19 with a single recommendation linking to the UK Health Security Agency ' s guidance for people with symptoms of a resp...
Source: Current Awareness Service for Health (CASH) - May 20, 2022 Category: Consumer Health News Source Type: news

Two-Drug Inhaler Could Reduce Asthma Attacks
Title: Two-Drug Inhaler Could Reduce Asthma AttacksCategory: Health NewsCreated: 5/19/2022 12:00:00 AMLast Editorial Review: 5/20/2022 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 20, 2022 Category: Respiratory Medicine Source Type: news

C-Section Antibiotics Show No Link to Asthma in Childhood
Title: C-Section Antibiotics Show No Link to Asthma in ChildhoodCategory: Health NewsCreated: 5/20/2022 12:00:00 AMLast Editorial Review: 5/20/2022 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 20, 2022 Category: Respiratory Medicine Source Type: news

Cold virus killed 100,000 children globally in 2019
Nearly half the deaths from respiratory syncytial virus were in babies aged under six months. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 20, 2022 Category: Consumer Health News Source Type: news

Montreal public health authority probing 17 cases of suspected monkeypox
Dr. Mylène Drouin, director of public health for the island of Montreal, says most cases of the disease, transmitted by close contact and respiratory droplets, are not severe, and there is no reason for people to panic. (Source: CBC | Health)
Source: CBC | Health - May 19, 2022 Category: Consumer Health News Tags: News/Canada/Montreal Source Type: news

Mozambique: Covid-19 - 20 New Cases and Four Recoveries
[AIM] Maputo -- The Mozambican health authorities on Wednesday reported 20 new cases of the Covid-19 respiratory disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 19, 2022 Category: African Health Source Type: news

Respiratory disease: applying All Our Health, PHE (updated 19th May 2022)
Evidence and guidance to help healthcare professionals manage respiratory disease and maximise early diagnosis and treatment. 19 May 2022Updated statistics for respiratory disease guidance. 4 October 2019Updated guidance on respiratory disease. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 19, 2022 Category: Consumer Health News Source Type: news

Mozambique: Covid-19 - 16 New Cases and Eight Recoveries
[AIM] Maputo -- The Mozambican health authorities on Tuesday announced a further 16 new cases of the Covid-19 respiratory disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 19, 2022 Category: African Health Source Type: news

Here's What Happened to Asthma, COPD Admissions After a Big Polluter Shut Down
(MedPage Today) -- SAN FRANCISCO -- For neighborhoods near a major coking operation in Pittsburgh, its shutdown at the end of 2015 was followed by markedly lower rates of respiratory disease hospitalizations, researchers reported here. Inpatient... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 18, 2022 Category: Allergy & Immunology Source Type: news

Asthma, Allergies Raise Heart Risks, Too
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 18, 2022 Category: Respiratory Medicine Tags: Cardiology, Pharmacy, Pulmonology, Allergy, News, Source Type: news

Living safely with respiratory infections, including COVID-19, UKHSA (updated 18th May 2022)
Guidance for living safely with respiratory infections, including coronavirus (COVID-19). 18 May 2022Added Russian and Ukrainian translations. 13 April 2022Added translations. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 18, 2022 Category: Consumer Health News Source Type: news

New Data Show TREMFYA ® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab
SPRING HOUSE, PENNSYLVANIA, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the mechanism of first-in-class TREMFYA® (guselkumab) from risankizumab due to the ability of TREMFYA to bind to CD64 positive (CD64+) cells in addition to interleukin (IL)-23 — both of which are key components of the immune system. 1,2 These findings, which are being presented at the Society for Investigative Dermatology (SID) annual meeting May 18-21, 2022 in Portland, Oregon, demonstrate TREMFYA bind...
Source: Johnson and Johnson - May 18, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news